These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure. Pivac N; Rumboldt Z; Sardelić S; Bagatin J; Polić S; Ljutić D; Naranca M; Capkun V Int J Clin Pharmacol Res; 1998; 18(3):121-8. PubMed ID: 9825268 [TBL] [Abstract][Full Text] [Related]
25. Initial responses of oedematous patients to furosemide and S1520. Leary WP; Asmal AC; Seedat YK; Samuel P S Afr Med J; 1974 Jan; 48(4):119-22. PubMed ID: 4596127 [No Abstract] [Full Text] [Related]
26. The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide. Sigurd B; Olesen KH; Wennevold A Am Heart J; 1975 Feb; 89(2):163-70. PubMed ID: 1090132 [TBL] [Abstract][Full Text] [Related]
27. Clinical trial of a new diuretic--metindamide. Burger P; Anderson IF S Afr Med J; 1974 Mar; 48(13):546-9. PubMed ID: 4596015 [No Abstract] [Full Text] [Related]
28. Open comparison of diuretic effects of piretanide and bumetanide in patients with stable renal transplants. Bailey RR N Z Med J; 1982 Jan; 95(700):44-5. PubMed ID: 7038567 [No Abstract] [Full Text] [Related]
29. Use of a new diuretic agent (metolazone) in patients with edema and ascites. Lowenthal DT; Shear L Arch Intern Med; 1973 Jul; 132(1):38-41. PubMed ID: 4716425 [No Abstract] [Full Text] [Related]
30. [Clinical comparative trial of piretanide and furosemide in patients with advanced renal insufficiency. Drug levels and diuretic potency of single oral doses]. Heuer LJ; Machnik H; Studt J; Fink R Arzneimittelforschung; 1983; 33(9):1318-21. PubMed ID: 6685516 [TBL] [Abstract][Full Text] [Related]
31. Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Ward A; Heel RC Drugs; 1984 Nov; 28(5):426-64. PubMed ID: 6391889 [TBL] [Abstract][Full Text] [Related]
32. Torasemide. A review of its pharmacological properties and therapeutic potential. Friedel HA; Buckley MM Drugs; 1991 Jan; 41(1):81-103. PubMed ID: 1706990 [TBL] [Abstract][Full Text] [Related]
33. Single dose comparison of torasemide and furosemide in patients with advanced renal failure. Klütsch K; Grosswendt J; Haecker W Arzneimittelforschung; 1988 Jan; 38(1A):200-4. PubMed ID: 3285834 [TBL] [Abstract][Full Text] [Related]
34. The sites of action of bumetanide in man. Bourke E; Asbury MJ; O'Sullivan S; Gatenby PB Eur J Pharmacol; 1973 Sep; 23(3):283-9. PubMed ID: 4583564 [No Abstract] [Full Text] [Related]
35. Bumetanide, a new loop diuretic. Carrière S; Dandavino R Clin Pharmacol Ther; 1976 Oct; 20(4):424-38. PubMed ID: 788989 [TBL] [Abstract][Full Text] [Related]
36. Discrepancy between bioavailability as estimated from urinary recovery of frusemide and total diuretic effect. Alván G; Paintaud G; Eckernäs SA; Grahnén A Br J Clin Pharmacol; 1992 Jul; 34(1):47-52. PubMed ID: 1633067 [TBL] [Abstract][Full Text] [Related]
37. [Dose-response relationship of bumetanide in healthy subjects]. Baethke VR; Kampf D Arzneimittelforschung; 1975 Apr; 25(4):666-8. PubMed ID: 1174085 [TBL] [Abstract][Full Text] [Related]
38. The diuretic effect of low dosage frusemide--a preliminary investigation. Baird IM; Longhurst N Curr Med Res Opin; 1972; 1(3):134-8. PubMed ID: 4668902 [No Abstract] [Full Text] [Related]